Frequently abnormal serum gamma-glutamyl transferase activity is associated with future development of fatty liver: a retrospective cohort study

European Association for the Study of the Liver (EASL), European Association for the Study of Diabetes (EASD) and European Association for the Study of Obesity (EASO) clinical practice recommendations for the management of non-alcoholic fatty liver diseas

(2018) A. L. Sberna et al.   DIABETIC MEDICINE

The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

(2017) Naga Chalasani et al.   HEPATOLOGY

New trends on obesity and NAFLD in Asia

(2017) Jian-Gao Fan et al.   JOURNAL OF HEPATOLOGY

Clinical epidemiology and disease burden of nonalcoholic fatty liver disease

(2017) Brandon J Perumpail et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Prevalence and Trends in Alcohol Dependence and Alcohol Use Disorders in Japanese Adults; Results from Periodical Nationwide Surveys

(2016) Yoneatsu Osaki et al.   ALCOHOL AND ALCOHOLISM

Association between serum γ-glutamyltransferase and chronic kidney disease in urban Han Chinese: a prospective cohort study

(2016) Zhen-Wei Shen et al.   INTERNATIONAL UROLOGY AND NEPHROLOGY

Gamma-glutamyltransferase-friend or foe within?

(2016) Setor K. Kunutsor   LIVER INTERNATIONAL

Obesity is an independent risk factor for non-alcoholic fatty liver disease: evidence from a meta-analysis of 21 cohort studies

(2016) L. Li et al.   Obesity Reviews

What does serum γ-glutamyltransferase tell us as a cardiometabolic risk marker?

(2016) Sudha Bulusu et al.   ANNALS OF CLINICAL BIOCHEMISTRY

Epidemiological modifiers of non-alcoholic fatty liver disease: Focus on high-risk groups

(2015) Amedeo Lonardo et al.   DIGESTIVE AND LIVER DISEASE

Evidence-based clinical practice guidelines for nonalcoholic fatty liver disease/nonalcoholic steatohepatitis

(2015) Sumio Watanabe et al.   JOURNAL OF GASTROENTEROLOGY

Triglycerides to high-density lipoprotein cholesterol ratio is an independent predictor of incident fatty liver; a population-based cohort study

(2015) Yukiko Fukuda et al.   LIVER INTERNATIONAL

Gamma glutamyltransferase and metabolic syndrome risk: a systematic review and dose-response meta-analysis

(2014) S. K. Kunutsor et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease

(2013) Shira Zelber-Sagi et al.   LIVER INTERNATIONAL

Gamma-glutamyltransferase levels and risk of metabolic syndrome: a meta-analysis of prospective cohort studies

(2012) C.-F. Liu et al.   INTERNATIONAL JOURNAL OF CLINICAL PRACTICE

Prevalence and risk factors for non-alcoholic fatty liver disease in Asian people who are not obese

(2012) Chun-Jen Liu   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

Genetic Covariance Between γ-Glutamyl Transpeptidase and Fatty Liver Risk Factors: Role of β2-Adrenergic Receptor Genetic Variation in Twins

(2010) Rohit Loomba et al.   GASTROENTEROLOGY

Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: The Framingham heart study

(2010) Elizabeth K. Speliotes et al.   HEPATOLOGY

Ultrasonographic hepatic steatosis increases prediction of mortality risk from elevated serum gamma-glutamyl transpeptidase levels

(2009) Robin Haring et al.   HEPATOLOGY